M. Liddament

Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab

L. Pukac, Jean Husten, D. Laine, 2018, Allergy, asthma & immunology research.

Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies

S. Mahler, Nadya Panagides, C. Owczarek, 2022, International journal of molecular sciences.

Retroviral restriction by APOBEC proteins

Reuben S. Harris, Mark T. Liddament, M. Liddament, 2004, Nature Reviews Immunology.

APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo

W. Brown, M. Liddament, April J. Schumacher, 2004, Current Biology.

Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain

M. Davenport, S. Kent, K. Subbarao, 2021, Cell Reports.

The Retroviral Hypermutation Specificity of APOBEC3F and APOBEC3G Is Governed by the C-terminal DNA Cytosine Deaminase Domain*

M. Liddament, G. Haché, R. Harris, 2005, Journal of Biological Chemistry.

Tracking Molecular Recognition at the Atomic Level with a New Protein Scaffold Based on the OB-Fold

V. Arcus, J. Rakonjac, J. Steemson, 2014, PloS one.